Tardive Dyskinesia

Tardive Dyskinesia is a movement problem that can happen after taking certain long-term medications, like some antipsychotics. It causes unwanted, repetitive movements, often in the face, tongue, or limbs. It's important to talk to your doctor if you think you might have this.

Condition

What people with Tardive Dyskinesia report

Every report comes from a Lived member, sent anonymously.

Have you tried Ingrezza (Valbenazine) for Tardive Dyskinesia?

NameHow it went

About Tardive Dyskinesia

What It Is

Tardive dyskinesia (TD) is a movement disorder caused by long-term use of certain medicines, most often antipsychotics. It produces repetitive movements a person cannot control, usually in the face and mouth: lip smacking or sucking motions, the tongue pushing out or against the cheek, puffed cheeks, grimacing and rapid blinking. Some people also have movements of the fingers, arms, legs or trunk, such as rocking or finger motions that look like playing the piano. "Tardive" means delayed. The movements usually appear after months or years on a medicine, not when it is first started. TD can be mild enough that a person barely notices it, or pronounced enough to interfere with everyday tasks, work and social life. It matters to recognize early because it can become long-lasting, and the chance of improvement is better when it is caught soon.

Causes & Risk Factors

TD develops after long-term use of medicines that block dopamine, a chemical messenger the brain uses to control movement. Antipsychotics, used for schizophrenia, bipolar disorder and other conditions, are the most common cause. Both older (first-generation) and newer (second-generation) antipsychotics can cause it, though the risk is lower with newer ones. In studies that pooled thousands of patients, roughly 1 in 5 people taking newer antipsychotics and 3 in 10 taking older ones had signs of TD. Metoclopramide (Reglan), a medicine for reflux and slow stomach emptying, can also cause TD, and so can some other anti-nausea medicines. The risk grows the longer someone takes the medicine and the higher the total amount taken over time, and the chance that TD becomes permanent rises the same way. Older adults, especially older women, are at higher risk, and with metoclopramide, so are people with diabetes. Even so, TD can appear after a fairly short course or at low doses, and there is no way to predict exactly who will develop it.

How It's Diagnosed

There is no blood test or scan for TD. A clinician diagnoses it by watching how a person moves and linking the movements to their medicine history: which dopamine-blocking drugs they have taken, for how long, and when the movements began. Many clinicians use the Abnormal Involuntary Movement Scale (AIMS), a short standardized exam that rates movements in each body region from none to severe. Repeating the same exam over time shows whether movements are new, getting worse or improving with treatment. Experts recommend regular movement checks for anyone taking these medicines, often every three to six months, so TD is noticed early. The evaluation also rules out look-alikes. Huntington's disease and other neurological conditions can cause similar movements, and brain imaging is sometimes used when another cause seems possible. Some side effects that start soon after a medicine is begun, such as sudden muscle spasms, stiffness and slowness, or an inner restlessness, are separate problems with different treatments.

Treatment Options

Treatment begins with the medicine causing TD. A prescriber may lower the dose, stop it, or switch to an antipsychotic with a lower TD risk, such as clozapine or quetiapine. For many people, though, the condition the antipsychotic treats makes stopping unwise, and some need to continue despite TD. That decision weighs the movements against the risk of the underlying illness returning, and it is made with the prescriber. Metoclopramide is different: its label says to stop it when signs of TD appear. Two medicines are approved by the US Food and Drug Administration specifically for TD in adults: valbenazine (Ingrezza) and deutetrabenazine (Austedo, Austedo XR). Both are vesicular monoamine transporter 2 (VMAT2) inhibitors, which reduce the amount of dopamine nerve cells release, calming the overactive movement signals behind TD. In clinical trials they reduced movement severity compared with a placebo, most participants kept taking their antipsychotic, and people who continued treatment tended to improve further over a year or more. They control symptoms rather than cure TD, so some benefit is lost if they are stopped. Sleepiness is the most common side effect, and they can cause parkinson-like stiffness or slowness. Because of drug interactions and possible effects on heart rhythm, the prescriber reviews other medicines and health conditions before starting one. Current psychiatric guidelines support their use. Anticholinergic medicines such as benztropine, which help some other drug-induced movement problems, do not help TD and can make it worse. Botulinum toxin injections can ease certain localized symptoms, and deep brain stimulation surgery is considered only in selected severe cases that have not responded to other treatment.

What to Expect

The course of TD varies widely. In some people the movements fade, partly or fully, after the causing medicine is reduced or stopped, especially when TD is caught early. In others it persists for years or is permanent. Antipsychotics can also partly hide the signs of TD, so movements can become more noticeable when the dose is lowered. Daily effects range from barely noticeable to significant. The movements can be uncomfortable, make some physical tasks harder and draw attention in public, which can affect work, relationships and emotional well-being. Many people improve meaningfully with a VMAT2 inhibitor. Follow-up visits repeat the movement exam to track progress, adjust the dose and watch for side effects. For people who still need an antipsychotic, ongoing care balances keeping the mental health condition stable with keeping movements as mild as possible.

When to Seek Help

If you take an antipsychotic, metoclopramide or another dopamine-blocking medicine, tell your prescriber about any new repetitive movements of the mouth, tongue, face, fingers or body, including movements family members notice. Keep regular movement checks even when you feel well. Do not stop or cut down an antipsychotic on your own, because the condition it treats can return; changes should be planned with the prescriber. If you take metoclopramide and notice these movements, contact the prescriber promptly, since that medicine is usually stopped when TD appears. Also contact the care team if a TD medicine causes heavy sleepiness, new stiffness or slowness, or restlessness. Very rarely, severe TD affects the muscles used for breathing; if the movements ever make it hard to breathe, call 911.

Questions to Ask Your Doctor

  1. 1.Are these movements tardive dyskinesia, or could another side effect or condition explain them?
  2. 2.Can my current medicine be lowered or changed, and what would that mean for the condition it treats?
  3. 3.Would valbenazine or deutetrabenazine make sense for me, and how will we judge whether it is working?
  4. 4.How often should my movements be checked, and what should my family and I watch for between visits?

Last reviewed • Oct 2026

Educational content, not medical advice.